Targeting the S1P receptor signaling pathways as a promising approach for treatment of autoimmune and inflammatory diseases
- 15 February 2019
- journal article
- review article
- Published by Elsevier BV in Pharmacological Research
- Vol. 154, 104170
- https://doi.org/10.1016/j.phrs.2019.02.009
Abstract
No abstract availableKeywords
Funding Information
- Swiss National Science Foundation
This publication has 100 references indexed in Scilit:
- Sphingosine 1-phosphate receptor 3 regulates recruitment of anti-inflammatory monocytes to microvessels during implant arteriogenesisProceedings of the National Academy of Sciences of the United States of America, 2013
- Fingolimod, a sphingosine-1 phosphate receptor modulator, increases BDNF levels and improves symptoms of a mouse model of Rett syndromeProceedings of the National Academy of Sciences of the United States of America, 2012
- Sphingosine 1-phosphate receptor 5 mediates the immune quiescence of the human brain endothelial barrierJournal of Neuroinflammation, 2012
- The selective sphingosine 1‐phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species‐specific effects on heart rateBritish Journal of Pharmacology, 2012
- Sphingosine-1-phosphate signaling and its role in diseaseTrends in Cell Biology, 2011
- Discovery, design and synthesis of the first reported potent and selective sphingosine-1-phosphate 4 (S1P4) receptor antagonistsBioorganic & Medicinal Chemistry Letters, 2011
- Sphingosine-1-Phosphate Receptor-2 Function in Myeloid Cells Regulates Vascular Inflammation and AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2011
- Production and characterization of monoclonal anti-sphingosine-1-phosphate antibodiesJournal of Lipid Research, 2009
- Synthesis and biological evaluation of sphingosine kinase substrates as sphingosine-1-phosphate receptor prodrugsBioorganic & Medicinal Chemistry, 2009
- Essential role of sphingosine 1–phosphate receptor 2 in pathological angiogenesis of the mouse retinaJCI Insight, 2007